Evidence map›Paper›PMID 31179826›Full record

ArticleGut microbes2020

Dietary iron variably modulates assembly of the intestinal microbiota in colitis-resistant and colitis-susceptible mice.

Melissa Ellermann, Raad Z Gharaibeh, Nitsan Maharshak, Ernesto Peréz-Chanona, Christian Jobin, Ian M Carroll, Janelle C Arthur, Scott E Plevy, Anthony A Fodor, Cory R Brouwer and 1 more

Open access · goldAbstract read
In one paragraph

Article in Gut microbes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Melissa EllermannDepartment of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA.
Raad Z GharaibehBioinformatics Services Division, Department of Bioinformatics and Genomics, University of North Carolina at Charlotte, Kannapolis, NC, USA.
Nitsan MaharshakDepartment of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, USA.
Ernesto Peréz-ChanonaDepartment of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA.
Christian JobinDepartment of Medicine, University of Florida, Gainesville, FL, USA.
Ian M CarrollDepartment of Medicine, University of North Carolina, Chapel Hill, NC, USA.
Janelle C ArthurDepartment of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA.ORCID 0000-0002-4796-0207
Scott E PlevyImmunology Research and Development, Janssen Pharmaceuticals, Spring House, PA, USA.
Anthony A FodorDepartment of Bioinformatics and Genomics, University of North Carolina at Charlotte, Charlotte, NC, USA.
Cory R BrouwerBioinformatics Services Division, Department of Bioinformatics and Genomics, University of North Carolina at Charlotte, Kannapolis, NC, USA.ORCID 0000-0003-4136-3249
R Balfour SartorDepartment of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA.
University of North Carolina at Chapel Hill · USUniversity of North Carolina at Charlotte · USJanssen (United States) · USTel Aviv University · ILUniversity of Florida · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David Darr · 1985 to 2026
$201.5M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Stephanie Engel · 2001 to 2026
$36.3M
UNIV OF NORTH CAROLINA CLINICAL NUTRITION RESEARCH UNITP30DK056350 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Ian Michael Carroll · 1999 to 2026
$31.6M
PILOT AND FEASIBILITY STUDIESP30DK034987 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Temitope O. Keku · 1985 to 2026
$30.5M
Role of IL-10 in APC Regulation of Protective vs. Pathogenic T Cell Responses toP01DK094779 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SHEIKH, SHEHZAD Z. · 2013 to 2023
$17.9M
National Gnotobiotic Rodent Resource CenterP40OD010995 · OD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Ryan B Sartor · 2012 to 2026
$9.7M
Colitis Induced by immune responses to luminal bacteria-mouseR01DK053347 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SARTOR, RYAN B · 1998 to 2012
$4.6M
Intestinal inflammation and genotoxicity of the colonic-adherent microbiotaK01DK103952 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ARTHUR, JANELLE C · 2014 to 2018
$758k
Howard Hughes Medical InstituteNCI NIH HHS P30 CA016086NIDDK NIH HHS K01 DK103952NIDDK NIH HHS P01 DK094779NIDDK NIH HHS P30 DK034987NIDDK NIH HHS P30 DK056350NIDDK NIH HHS R01 DK053347NIEHS NIH HHS P30 ES010126NIH HHS P40 OD010995
6 · The paper itself

Abstract

Iron deficiency, a common comorbidity of gastrointestinal inflammatory disorders such as inflammatory bowel diseases (IBD), is often treated with oral iron supplementation. However, the safety of oral iron supplementation remains controversial because of its association with exacerbated disease activity in a subset of IBD patients. Because iron modulates bacterial growth and function, one possible mechanism by which iron may exacerbate inflammation in susceptible hosts is by modulating the intestinal microbiota. We, therefore, investigated the impact of dietary iron on the intestinal microbiota, utilizing the conventionalization of germ-free mice as a model of a microbial community in compositional flux to recapitulate the instability of the IBD-associated intestinal microbiota. Our findings demonstrate that altering intestinal iron availability during community assembly modulated the microbiota in non-inflamed wild type (WT) and colitis-susceptible interleukin-10-deficient (

Indexed as

AnimalsColitisColonDisease Models, AnimalDisease SusceptibilityDysbiosisEnterobacteriaceaeEscherichia coliGastrointestinal MicrobiomeGenetic Predisposition to DiseaseInflammationInflammatory Bowel DiseasesInterleukin-10IntestinesIron, DietaryMiceIL10 protein, humanInterleukin-10Iron, DietaryAnimal models of GI-diseases with microbial componentscolitisDefining/profiling gut microbiomeDietary ironEscherichia coligut microbiomeIBDRole of gut microbiome in GI disease

Identifiers

PMID31179826
PMCPMC6973310
OpenAlexW2952947956

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.